Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 5'-(4-fluorosulfonylbenzoyl)adenosine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 5'-(4-fluorosulfonylbenzoyl)adenosine in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(5'-(4-fluorosulfonylbenzoyl)adenosine)		Trials
(5'-(4-fluorosulfonylbenzoyl)adenosine)		Recent Studies (post-2010) (5'-(4-fluorosulfonylbenzoyl)adenosine)
9,15618755221513

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dangelmaier, C; Hassell, B; Holmsen, H; Rao, AK; Smith, JB; Willis, J1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 5'-(4-fluorosulfonylbenzoyl)adenosine

ArticleYear
Platelet-activating factor is a weak platelet agonist: evidence from normal human platelets and platelets with congenital secretion defects.
    American journal of hematology, 1984, Volume: 17, Issue:2

    Topics: Adenosine; Adenosine Triphosphate; Arachidonic Acid; Arachidonic Acids; Blood Platelet Disorders; Humans; Platelet Activating Factor; Platelet Aggregation; Serotonin; Thrombin; Thromboxanes

1984